Phase
Condition
Sarcoma
Treatment
Intensity Modulated Radiation Therapy (IMRT)
MRI
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Provision of signed and dated informed consent form
Stated willingness to comply with all study procedures and availability for theduration of the study
For women of childbearing potential: use of highly effective contraception for atleast 1 month prior to screening and agreement to use such a method during studyparticipation and for an additional 52 weeks after the end of radiation.
For males of reproductive potential: use of condoms or other methods to ensureeffective contraception with partner 52 weeks after radiation.
Agreement to adhere to Lifestyle Considerations (as outlined in protocol) throughoutstudy duration.
Pathologically (histologically or cytologically) proven diagnosis of high-grade (grade 2 or 3) Soft Tissue Sarcoma (STS) of the deep trunk and/or extremity.Clinical evidence should be documented, and may consist of pathology or imaging, andshould be sufficient to estimate the size of the primary (for T stage)
Primary site deemed resectable prior to the start of trial
American Joint Committee on Cancer (AJCC) 8th edition staging T1-4 N0 M0, noevidence of distant metastases
Patients must have clinically or radiographically evident measurable disease at theprimary site.
Pre-Radiation Therapy (RT) MRI within 4 weeks of the start of RT.
Eastern Cooperative Oncology Group (ECOG) Performance Status 0 to 3.
Deemed a surgical candidate
Participant agrees to blood and plasma preservation for future analysis.
Exclusion
Exclusion Criteria:
Contraindications to an MRI
Positive urine pregnancy test
Gross total excision of primary STS, including an unplanned excision
Superficial sarcoma located primarily in the subcutaneous or cutaneous tissue
Prior radiation to the region of the study cancer that would result in overlap ofradiation therapy fields.
Participants with a medical condition or social situation that, at the discretion ofthe principal investigator, would preclude them from completion of the trial.
Study Design
Connect with a study center
Moffitt Cancer Center
Tampa, Florida 33612
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.